Left atrial epicardial adipose tissue volume quantification by CMR aids identification of patients at low risk for left atrial cardiomyopathy
The pre-procedural identification of a low risk of atrial cardiomyopathy is important to select patients for single-shot catheter ablation. LA-EATVi proved to be of additive value to known risk factors for the prediction of LVZ in a combined prediction model. Patients not considered low risk could be offered an electroanatomic atrial mapping for LVZ detection with the possibility of an LVZ-based radiofrequency ablation approach. Individualized matching of patient and ablation technique using an LVZ prediction model might lead to improved ablation outcomes.
Authors
- Thomas Schmidt (ORCID: https://orcid.org/0000-0002-1475-2559)
- Felix Matthias Heidrich (ORCID: https://orcid.org/0000-0002-1972-8216)
- Michael Wagner (ORCID: https://orcid.org/0000-0002-6300-5752)
- Stefan Ulbrich (ORCID: https://orcid.org/0000-0003-1052-1013)
- Susan Richter (ORCID: https://orcid.org/0000-0002-3549-2477)
- Thomas Gaspar (ORCID: https://orcid.org/0000-0002-8110-6290)
- Axel Linke
Institutions
- University Hospital Carl Gustav Carus (DE)
Publication Details
- Journal
- Clinical Research in Cardiology
- Published
- 2025-09-03
- DOI
- https://doi.org/10.1007/s00392-025-02718-0
- Primary Topic
- Cardiovascular Disease and Adiposity
- Type
- article
- Field-Weighted Citation Impact
- 0.00